NCT00258193View on ClinicalTrials.gov

Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

September 30, 2006

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

MD-1100 Acetate

Trial Locations (1)

Unknown

Mayo Clinic Foundation, Rochester

Sponsors
All Listed Sponsors
lead

Ironwood Pharmaceuticals, Inc.

INDUSTRY